A Case of Upper Tract Urothelial Carcinoma With Neuroendocrine Differentiation Successfully Treated With Enfortumab Vedotin and Pembrolizumab

ABSTRACT Introduction Upper tract urothelial carcinoma with neuroendocrine differentiation (UC‐NE) is extremely rare and generally associated with aggressive behavior and poor prognosis. Optimal treatment strategies remain unclear, particularly regarding the role of nectin‐4–targeted therapy. Case P...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Kosei Taniguchi, Mamoru Hashimoto, Takahito Nakayama, Saizo Fujimoto, Shingo Toyoda, Takashi Kikuchi, Marco Antonio De Velasco, Osamu Maenishi, Takafumi Minami, Kazutoshi Fujita
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Wiley 2026-03-01
Serie:	IJU Case Reports
Soggetti:	Enfortumab vedotin Nectin‐4 neuroendocrine differentiation pembrolizumab upper tract urothelial carcinoma
Accesso online:	https://doi.org/10.1002/iju5.70149
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!